California Abortion Pill Suppliers Stock Misoprostol

California-based abortion pill suppliers have prepared immediate backup plans in case the Supreme Court allows restrictions on mifepristone to take effect after a May 11 deadline. The suppliers say they can switch within a day to shipping misoprostol alone, a drug already used in combination with mifepristone for most medication abortions.

The Supreme Court issued a temporary stay blocking a lower court decision that would reinstate requirements for in-person dispensing of mifepristone. That ruling from the appeals court would have effectively ended telehealth prescriptions and nationwide mailing of the drug.

The temporary pause expires May 11 unless the justices extend it or issue a final ruling. Mifepristone is used in nearly two-thirds of all U.S. abortions. Between a quarter and a third of those prescriptions now come through telehealth providers and are delivered by mail.

Suppliers moved quickly after learning of the latest legal development. "We heard about this on Friday and organizations that mail pills were mailing misoprostol on Saturday," one provider told reporters. " The supply chain is "ready to switch in a day" to the alternative, according to the same source.

Misoprostol alone is less effective than the two-drug combination and carries a higher risk of side effects and more pain for patients, according to health assessments. The Supreme Court then stepped in with an administrative stay to maintain wider access while it considers the case.

After the Supreme Court overturned the constitutional right to abortion in 2022, California enshrined abortion rights in its constitution and passed laws protecting clinicians who prescribe pills to patients in states with bans. State legislators later expanded those protections by allowing pills to be mailed without attaching the doctor or patient's name.

Even with those state-level safeguards, a Supreme Court decision favoring restrictions could create a two-tiered system of abortion access. Patients in rural areas or with fewer resources would face greater barriers, while those able to reach clinics in person could still obtain the two-drug regimen.

Legal experts cited in reporting are divided on how the justices will ultimately rule. Some suggest the court may consider an 1873 law that prohibits mailing items used to produce abortions, though that provision has not been enforced in decades. A decision invoking that law could affect access to both abortion medication and certain forms of contraception.

Providers emphasize that care will continue regardless of the outcome. "It's not going away and it's not going to slow down," one co-founder of a virtual reproductive healthcare network said. Organizations have already demonstrated they can pivot quickly to the alternative protocol.

The case highlights ongoing tensions between state protections for abortion access and federal court rulings that could limit how those services are delivered across state lines. National data show abortion patients are disproportionately poor and many are already mothers.

“The supply chain is ready to switch in a day to an alternative drug combination. It's not going away and it's not going to slow down.”

Suppliers and clinicians say their focus remains on ensuring medications reach people who need them while lawyers and courts continue to debate the rules.